Listen "How C2i Genomics builds on AWS to transform cancer care"
Episode Synopsis
Healthcare and life sciences (HCLS) startups recognize that technology is an impactful vehicle for advancing human health at speed and scale. More importantly, HCLS startups are working to do something about it. C2i Genomics, founded in 2019, is one such startup: C2i Genomics is building a whole genome intelligence platform to improve cancer monitoring. Using artificial intelligence (AI) and machine learning (ML) solutions, C2i Genomics’ platform analyzes sequenced genome data to detect the tumor burden of cancer patients via a simple blood test.
More episodes of the podcast AWS Startups Blog
AWS and CrowdStrike announce the winner of the AWS & CrowdStrike Cybersecurity Accelerator
14/05/2024
Boosted.ai’s generative AI portfolio manager surfaces near-instant finance insights with AWS
07/05/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.